Why is the IBDX panel better than other existing serological tests?
Crohn’s disease is complex disease which manifests itself in many ways. It varies according to location, behavior, severity and activity. Considered a multifactor disease, as a result CD requires a combination of serological markers (panel) testing for a full diagnosis. Many patients can show negative for one serological marker, yet positive for another. In general, the more markers a patient has – the more aggressive disease behavior he or she might suffer. Studies have been shown that the IBDX panel has a high degree of sensitivity (the ability to diagnose a condition) while maintaining high specificity (insuring that people who receive positive results actually have the disease) for IBD differential diagnosis. Therefore the IBDX panel identifies more patients at high accuracy than other serological solutions. The IBDX panelIBDX panel enables you to e tested as early as the first presentation (onset) of your disease. Glycominds’ IBDX panel of serological markers can assist your docto
